0001891891-21-000001.txt : 20211103 0001891891-21-000001.hdr.sgml : 20211103 20211103172355 ACCESSION NUMBER: 0001891891-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211103 DATE AS OF CHANGE: 20211103 EFFECTIVENESS DATE: 20211103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Quanta Therapeutics, Inc. CENTRAL INDEX KEY: 0001891891 IRS NUMBER: 831445023 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-419719 FILM NUMBER: 211376681 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BLVD. SOUTH RM 322 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: (650) 799-8230 MAIL ADDRESS: STREET 1: 455 MISSION BAY BLVD. SOUTH RM 322 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001891891 Quanta Therapeutics, Inc. 455 MISSION BAY BLVD. SOUTH RM 322 SAN FRANCISCO CA CALIFORNIA 94158 (650) 799-8230 DELAWARE None None Corporation true 2018 Perry Nisen 455 Mission Bay Blvd. South RM 322 San Francisco CA CALIFORNIA 94158 Executive Officer Director Maria Fardis 455 Mission Bay Blvd. South RM 322 San Francisco CA CALIFORNIA 94158 Director Arjun Goyal 455 Mission Bay Blvd. South RM 322 San Francisco CA CALIFORNIA 94158 Director Maha Katabi 455 Mission Bay Blvd. South RM 322 San Francisco CA CALIFORNIA 94158 Director Cameron Pitt 455 Mission Bay Blvd. South RM 322 San Francisco CA CALIFORNIA 94158 Director Samuel Saks 455 Mission Bay Blvd. South RM 322 San Francisco CA CALIFORNIA 94158 Director Biotechnology Decline to Disclose 06b false 2021-10-20 false true false 0 70152314 40152323 29999991 false 10 0 0 0 false Quanta Therapeutics, Inc. /s/ Perry Nisen Perry Nisen Chief Executive Officer 2021-11-03